Executive OfficerTitle BonusMarco Taglietti, M.D.Chief Executive Officer$210,100David Angulo, M.D.Chief Medical Officer$136,600Eric FrancoisChief Financial Officer$113,000
EX-10.34 3 exhibit1034.htm EXHIBIT 10.34 Exhibit
Exhibit 10.34
On January 31, 2017, the Board of Directors of SCYNEXIS, Inc. took the following compensation actions with respect to SCYNEXIS’s following executive officers (collectively, the “Officers”):
2016 Officer Bonuses
Approved cash bonuses for the Officers based on SCYNEXIS’s performance for the calendar year 2016:
Executive Officer | Title | Bonus | ||
Marco Taglietti, M.D. | Chief Executive Officer | $210,100 | ||
David Angulo, M.D. | Chief Medical Officer | $136,600 | ||
Eric Francois | Chief Financial Officer | $113,000 | ||
2017 Salaries
Approved the 2017 salaries for the Officers, to be effective March 1, 2017, as follows:
Executive Officer | Title | 2017 Salary | ||
Marco Taglietti, M.D. | Chief Executive Officer | $510,000 | ||
David Angulo, M.D. | Chief Medical Officer | $413,800 | ||
Eric Francois | Chief Financial Officer | $360,500 | ||
Option Grants
Approved stock option grants under SCYNEXIS 's 2014 Equity Incentive Plan to the following Officers:
Executive Officer | Title | Shares subject to Option | ||
Marco Taglietti, M.D. | Chief Executive Officer | 360,000 | ||
David Angulo, M.D. | Chief Medical Officer | 140,000 | ||
Eric Francois | Chief Financial Officer | 100,000 | ||
The options have an exercise price of $3.02 per share and vest on a monthly basis over a four-year period, provided such officer is continuing to provide services to SCYNEXIS on such vesting date.
